Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative BMAC in Hip Arthroscopy
NCT06750757Phase 4Not yet recruiting
- Sponsor
- American Hip Institute
- Start
- Feb 2025
- Primary completion
- Feb 2027
- Modality
- Stem Cell Therapies
01
Overview
A Phase 4 trial of autologous bone marrow cell concentrate in Femoroacetabular impingement (FAI), Labral tear, sponsored by American Hip Institute. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
Femoroacetabular impingement (FAI)Labral tear
Beyond the preview
Go deeper on NCT06750757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06750757.